Interventional cardiology

Ayal Willner, MD, is recognized by Continental Who's Who

Retrieved on: 
Friday, January 27, 2023
Multimedia, MD, Miller Children's Hospital, Head, Education, ENT, Mending Kids International, Cornell University, American Board of Commissioners for Foreign Missions, Private practice, Continental, George Washington University, Hospital, Le Bonheur Children's Hospital, American Academy, Castle Connolly Medical, Interventional cardiology, Otorhinolaryngology, American Academy of Otolaryngology–Head and Neck Surgery, Long Beach Memorial Medical Center, Albert Einstein College of Medicine, Tonsillectomy, National Institute of Ear, Nose and Throat, Bangladesh, Society, Pediatrics (journal), American College, Assistant, Dentistry, Biology, Pediatrics, Child

Dr. Ayal Willner began his college education at Cornell University, graduating with a Bachelor of Science degree in Biology.

Key Points: 
  • Dr. Ayal Willner began his college education at Cornell University, graduating with a Bachelor of Science degree in Biology.
  • He is board-certified by the American Board of Otolaryngology - Head & Neck Surgery and has been in the medical profession for over 30 years.
  • Dr. Willner is a Pediatric Otolaryngologist specialist with a private practice called Southern California Ear Nose and Throat (SCENT).
  • Dr. Willner treats children and adults, addressing a wide range of issues and performing complex ear, sinus, and skull surgeries.

Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status

Retrieved on: 
Tuesday, January 31, 2023
Consensus, Journal, IVL, Cardiovascular disease, Interventional cardiology, Hospital, Society, SCAI, Catheter, Intervention, Physician, Patient, FDA, Angiography, Calcium, Consultant, Health, Medical device

The latest guidance – SCAI Expert Consensus Statement on PCI Without On-Site Surgical Backup – was published online in the Journal of the Society of Cardiovascular Angiography and Intervention (JSCAI).

Key Points: 
  • The latest guidance – SCAI Expert Consensus Statement on PCI Without On-Site Surgical Backup – was published online in the Journal of the Society of Cardiovascular Angiography and Intervention (JSCAI).
  • The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified coronary lesions.
  • “The previous guidelines required these patients in facilities without surgical backup be transferred interprocedurally via an ambulance to a cath lab with onsite surgical backup.
  • The 2014 guidelines recommended avoiding treatment of high-risk lesions defined as “more than moderate calcification” in facilities without surgical backup.

Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series

Retrieved on: 
Tuesday, January 31, 2023
Columbia University Irving Medical Center, NewYork-Presbyterian Hudson Valley Hospital, Safety, Navigation, Vision Guided Robotic Systems, Health, FIH, PCI, Web conferencing, Physician, Patient, Q&A, Public, Time-invariant system, Interventional cardiology, Clinical trial, Siemens Healthineers, Faculty, Cardiology, Corindus Vascular Robotics, Associate, Medical device, Medicine

HINGHAM, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful “Access-Ability Live by MBOT” webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at 1:00pm ET. It will be hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.

Key Points: 
  • It will be hosted by the Company’s Chief Medical Officer, Dr. Eyal Morag.
  • He is also a faculty member at the Cardiovascular Research Foundation in New York.
  • Dr. Weisz, who has a particular interest in current and innovative technologies in cardiovascular medicine, is an early adopter of robotic-enhanced coronary interventions, as well as navigation and positioning technologies.
  • The “Access-Ability Live by MBOT” webinar series focuses on key topics in the healthcare and endovascular space.

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

Retrieved on: 
Wednesday, January 11, 2023
Medical Devices, Other Health, Health, Clinical Trials, Cardiology, De novo, OAS, Trial of the century, Interventional cardiology, Diamondback, Safety, Coronary artery disease, Stent, Plaque, Patient, Artery, Atherosclerosis, CSI, Popliteal artery, KAIZEN, PAD, Physician, Peripheral artery disease, Pharmaceutical industry, Medical device, Medical imaging

The first KAIZEN patient was enrolled by Tatsuya Nakama, M.D., Vice Director, Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.

Key Points: 
  • The first KAIZEN patient was enrolled by Tatsuya Nakama, M.D., Vice Director, Department of Cardiology, Tokyo Bay Urayasu Ichikawa Medical Center.
  • Dr. Nakama said, “I felt that the Diamondback 360© Peripheral OAS offered both effective treatment and ease of use.
  • OAS has demonstrated safety and efficacy in the U.S. population and this study is designed to confirm this in Japan.
  • I believe the Diamondback 360© Peripheral OAS has great potential for this underserved patient population, and I look forward to evaluating it in Japan.

HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND'S INNOVESTOR LIFE SCIENCE FUND AND TESI

Retrieved on: 
Thursday, January 12, 2023
Partner, Adrenal insufficiency, Development, Boston Scientific, HVR, MR, Health, GM, Hope, Structural heart disease, Interventional cardiology, VC, Patient, Helix, Valvular heart disease, Management, Pharmaceutical industry, Medical imaging, Financial services, Təsi, Research

HELSINKI, Finland and MINNEAPOLIS, Jan. 12, 2023 /PRNewswire/ -- HVR Cardio, a clinical stage medical technology company developing Structural Heart cardiovascular products for transcatheter mitral valve repair, announced today that it has closed on its 10.7 million Euro ($11.1M US) Series B Round of financing. This Series B Round was led by Innovestor Life Science Fund and Tesi, both headquartered in Finland.

Key Points: 
  • This Series B Round was led by Innovestor Life Science Fund and Tesi, both headquartered in Finland.
  • HVR Cardio is developing a transformative technology for transcatheter mitral valve repair with its CathHELIX™ Annuloplasty System, for use by Structural Heart Physicians to treat mitral regurgitation (MR).
  • "The potential of this innovative technology is why I joined the team," said Tom Fleming, CEO HVR Cardio.
  • HVR Cardio is a Finnish cardiovascular device company that is developing breakthrough solutions for mitral valve repair based on its proprietary helix technology.

Ayal Willner, MD is recognized by Continental Who's Who

Retrieved on: 
Monday, November 28, 2022
American Academy of Otolaryngology–Head and Neck Surgery, Tonsillectomy, Head, Otorhinolaryngology, Hospital, American College, ENT, Sleep apnea, Multimedia, Le Bonheur Children's Hospital, Long Beach Memorial Medical Center, George Washington University, Education, Society, Miller Children's Hospital, MD, Cornell University, American Board of Commissioners for Foreign Missions, Fellowship of the Royal Colleges of Surgeons, Assistant, Private practice, Mending Kids International, Albert Einstein College of Medicine, American Academy, National Institute of Ear, Nose and Throat (ENT), Bangladesh, Interventional cardiology, Continental, Pediatrics (journal), Medicine, Dentistry, Pediatrics, Child, Biology

LONG BEACH, Calif., Nov. 28, 2022 /PRNewswire/ -- Ayal Willner, MD, is being recognized by Continental Who's Who as a Distinguished Otolaryngologist, Partner, and Owner in the medical field and in acknowledgment of his professional excellence at Southern California Ear Nose and Throat (SCENT).

Key Points: 
  • LONG BEACH, Calif., Nov. 28, 2022 /PRNewswire/ -- Ayal Willner, MD, is being recognized by Continental Who's Who as a Distinguished Otolaryngologist, Partner, and Owner in the medical field and in acknowledgment of his professional excellence at Southern California Ear Nose and Throat (SCENT).
  • Dr. Willner is a Pediatric Otolaryngologist specialist with his own private practice called Southern California Ear Nose and Throat (SCENT).
  • Dr. Ayal Willner began his college education at Cornell University, graduating with a Bachelor of Science degree in Biology.
  • He later received his medical degree and completed an Otolaryngology residency at the Albert Einstein College of Medicine.

Global Contrast Media Injectors Market Report 2022: Regulatory Approval of an Increasing Number of Contrast Agents Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, November 7, 2022
Health, Medical Supplies, Medical Devices, Observation, Industry, Midsayap Diagnostic Center and Hospital, Ansoff Matrix, Growth, CAGR, Market development, Geography, Interventional radiology, USD, SWOT, Hospital, Investment, Consumables, Interventional cardiology, COVID-19, Porter's five forces analysis, Risk, Radiology, Medical device, Retail, Risk management, Pharmaceutical industry

The Global Contrast Media Injectors Market is segmented based on Product, Applications, End User, and Geography.

Key Points: 
  • The Global Contrast Media Injectors Market is segmented based on Product, Applications, End User, and Geography.
  • The report presents a detailed Ansoff matrix analysis for the Global Contrast Media Injectors Market.
  • The analyst analyses the Global Contrast Media Injectors Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • The report offers a comprehensive evaluation of the Global Contrast Media Injectors Market.

Viz.ai Launches AI-Powered VizTM Cardio Suite

Retrieved on: 
Friday, November 4, 2022
Apps, Applications, Technology, Medical Devices, Hospitals, Health Technology, Cardiology, Radiology, Health, Artificial Intelligence, American Heart Association, Therapy, Pulmonary embolism, Algorithm, Hospital, Cardiology, Multimedia, Neurology, AI, Degenerative disease, FDA, Death, Stroke, Massachusetts General Hospital, Viz, Machine learning, CEO, Completeness, Interventional cardiology, Cardiovascular disease, Partnership, Intervention, Disease, Technology, Atrial fibrillation, AHA, Diagnosis, Patient, HEART, Medical device, Medical imaging, Pharmaceutical industry

Announced during the American Heart Association (AHA) Scientific Sessions, Viz Cardio Suite leverages AI-powered disease detection, workflow optimization, and care team coordination to provide efficiencies in the delivery of cardiovascular care.

Key Points: 
  • Announced during the American Heart Association (AHA) Scientific Sessions, Viz Cardio Suite leverages AI-powered disease detection, workflow optimization, and care team coordination to provide efficiencies in the delivery of cardiovascular care.
  • Both are part of the comprehensive Viz Cardio Suite designed to speed and improve patient access to innovative cardiovascular treatments.
  • With its Cardio Suite, Viz.ai is streamlining care pathways by improving patient identification, developing disease-specific workflows and connecting patients to the right provider in their medical journey.
  • Not only does the Viz Cardio Suite leverage AI to detect more disease in more patients, but it also accelerates the care pathway.

NJ Top Docs Proudly Presents Dr. Rick J. Pumill of Cross County Cardiology for 2022

Retrieved on: 
Friday, October 28, 2022
MD, Hypertension, Interventional cardiology, Cardiovascular disease, Coronary artery disease, Pregnancy, Patient, World, Vascular disease, Cardiology, Hospital, Dentist, Adult, Medical device, Medical imaging, Pharmaceutical industry, Newsweek

SCOTCH PLAINS, N.J., October 28, 2022 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved board-certified cardiologist, Rick J. Pumill, MD of Cross County Cardiology for 2022.

Key Points: 
  • Board-certified cardiologist, Dr. Rick J. Pumill of Cross County Cardiology has been reviewed and approved by NJ Top Docs for 2022.
  • SCOTCH PLAINS, N.J., October 28, 2022 /PRNewswire-PRWeb/ -- NJ Top Docs has reviewed and approved board-certified cardiologist, Rick J. Pumill, MD of Cross County Cardiology for 2022.
  • With more than 33 years of experience, Dr. Pumill and his team at Cross County Cardiology specialize in Cardiovascular Disease, Vascular Disease, Coronary Artery Disease, Interventional Cardiology, Adult Cardiology, Nuclear Cardiology, Pregnancy and Heart Disease, Preventive Cardiology, Lipid Disorders and Hypertension.
  • I highly recommend Dr. Pumill and Cross County Cardiology," says patient Julie S.
    Dr. Pumill is affiliated with Mt.

Healthcare Triangle Helps Lane Regional Deliver Value-based Care with MEDITECH Chronic Care Management (CCM)

Retrieved on: 
Tuesday, October 25, 2022
Cloud, Certification, Construction, NASDAQ, Efficiency, BSN, Case management, Medicine, Radiation therapy, Adoption, MEDITECH, Technology, Documentation, Patient, Compliance, Advance care planning, Workflow, HCTI, Lane, Program, Pediatrics, Hospital, Interventional cardiology, OB/GYN, CCM, RN, Aiken Regional Medical Center, Physician, Health insurance, Medical device

Healthcare Triangles MEDITECH Ready-Certified consultants assisted in setting up new functionality in MEDITECH Expanse for Chronic Care Management.

Key Points: 
  • Healthcare Triangles MEDITECH Ready-Certified consultants assisted in setting up new functionality in MEDITECH Expanse for Chronic Care Management.
  • HCTI experts went above and beyond to deliver a solution leveraging MEDITECH functionality to streamline Case Management workflow.
  • She brought so much knowledge to the table and helped us refine our documentation and processes, says Amy Rome, RN, BSN, Chronic Care Management Nurse Navigator, Lane Regional Medical Center.
  • Healthcare Triangle, Inc. (NASDAQ: HCTI), based in Pleasanton, Calif., reinforces healthcare progress through breakthrough technology and extensive industry know-how.